Cecilia J. Tsang

Array ( [id] => 2457368 [patent_doc_number] => 04785001 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1988-11-15 [patent_title] => 'Ergoline esters' [patent_app_type] => 1 [patent_app_number] => 7/052380 [patent_app_country] => US [patent_app_date] => 1987-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1370 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/785/04785001.pdf [firstpage_image] =>[orig_patent_app_number] => 052380 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2548447 [patent_doc_number] => 04804757 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1989-02-14 [patent_title] => 'Pyrimidinylsulfonyl carbamates and thiocarbamates' [patent_app_type] => 1 [patent_app_number] => 7/050656 [patent_app_country] => US [patent_app_date] => 1987-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11442 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/804/04804757.pdf [firstpage_image] =>[orig_patent_app_number] => 050656 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2494126 [patent_doc_number] => 04847287 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1989-07-11 [patent_title] => 'Pure enantiomers of 4,5-disubstituted gamma-butyrolactams, and their use as antiamnestic agents' [patent_app_type] => 1 [patent_app_number] => 7/050604 [patent_app_country] => US [patent_app_date] => 1987-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9168 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/847/04847287.pdf [firstpage_image] =>[orig_patent_app_number] => 050604 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2516718 [patent_doc_number] => 04863927 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1989-09-05 [patent_title] => '1-(2-hydroxymethyl)cycloalkylmethyl)-5-substituted uracils' [patent_app_type] => 1 [patent_app_number] => 7/048290 [patent_app_country] => US [patent_app_date] => 1987-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2768 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/863/04863927.pdf [firstpage_image] =>[orig_patent_app_number] => 048290 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2554163 [patent_doc_number] => 04814449 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1989-03-21 [patent_title] => 'Substance 4181-2' [patent_app_type] => 1 [patent_app_number] => 7/048297 [patent_app_country] => US [patent_app_date] => 1987-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4570 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/814/04814449.pdf [firstpage_image] =>[orig_patent_app_number] => 048297 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2392756 [patent_doc_number] => 04782063 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1988-11-01 [patent_title] => 'Ergoline esters useful as serotonin antagonists' [patent_app_type] => 1 [patent_app_number] => 7/048166 [patent_app_country] => US [patent_app_date] => 1987-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4867 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 156 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/782/04782063.pdf [firstpage_image] =>[orig_patent_app_number] => 048166 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2418474 [patent_doc_number] => 04771061 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1988-09-13 [patent_title] => 'Substituted piperazine-1,4-naphthalenediones useful for treating asthma, allergic diseases and/or inflammation' [patent_app_type] => 1 [patent_app_number] => 7/046365 [patent_app_country] => US [patent_app_date] => 1987-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7274 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/771/04771061.pdf [firstpage_image] =>[orig_patent_app_number] => 046365 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2546636 [patent_doc_number] => 04804662 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1989-02-14 [patent_title] => 'Substituted 4-(1H-imidazol-1-yl)benzamides as antiarrhythmic agents' [patent_app_type] => 1 [patent_app_number] => 7/046222 [patent_app_country] => US [patent_app_date] => 1987-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7413 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 407 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/804/04804662.pdf [firstpage_image] =>[orig_patent_app_number] => 046222 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2546595 [patent_doc_number] => 04804660 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1989-02-14 [patent_title] => 'Ergot cyclic peptide alkaloids having a venotonizing effect, useful for treating orthostatic hypotension' [patent_app_type] => 1 [patent_app_number] => 7/047362 [patent_app_country] => US [patent_app_date] => 1987-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7648 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 160 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/804/04804660.pdf [firstpage_image] =>[orig_patent_app_number] => 047362 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2468977 [patent_doc_number] => 04845224 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1989-07-04 [patent_title] => 'Cycloalkanol esters of dihydrolysergic acid having peripheral serotonin antagonist properties' [patent_app_type] => 1 [patent_app_number] => 7/043780 [patent_app_country] => US [patent_app_date] => 1987-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4552 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/845/04845224.pdf [firstpage_image] =>[orig_patent_app_number] => 043780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2516847 [patent_doc_number] => 04874765 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1989-10-17 [patent_title] => '1,4-Disubstituted piperazines having dopaminergic activity' [patent_app_type] => 1 [patent_app_number] => 7/041206 [patent_app_country] => US [patent_app_date] => 1987-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10113 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/874/04874765.pdf [firstpage_image] =>[orig_patent_app_number] => 041206 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2483383 [patent_doc_number] => 04866062 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1989-09-12 [patent_title] => '1,4-disubstituted piperazines, pharmaceutical compositions thereof and method of use' [patent_app_type] => 1 [patent_app_number] => 7/041234 [patent_app_country] => US [patent_app_date] => 1987-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5282 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/866/04866062.pdf [firstpage_image] =>[orig_patent_app_number] => 041234 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2487382 [patent_doc_number] => 04868184 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1989-09-19 [patent_title] => 'Benzhydrylpiperazines pharmaceutical compositions thereof and method of use' [patent_app_type] => 1 [patent_app_number] => 7/041233 [patent_app_country] => US [patent_app_date] => 1987-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6678 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/868/04868184.pdf [firstpage_image] =>[orig_patent_app_number] => 041233 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2489697 [patent_doc_number] => 04859682 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1989-08-22 [patent_title] => '2-Halogenated-8- and 1,8-substituted ergolenes' [patent_app_type] => 1 [patent_app_number] => 7/040938 [patent_app_country] => US [patent_app_date] => 1987-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6380 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/859/04859682.pdf [firstpage_image] =>[orig_patent_app_number] => 040938 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2420854 [patent_doc_number] => 04788196 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1988-11-29 [patent_title] => 'Phenyl piperazine anti-arrhythmia agents' [patent_app_type] => 1 [patent_app_number] => 7/039508 [patent_app_country] => US [patent_app_date] => 1987-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8091 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/788/04788196.pdf [firstpage_image] =>[orig_patent_app_number] => 039508 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2544093 [patent_doc_number] => 04832729 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1989-05-23 [patent_title] => 'Picolinic acid derivatives and herbicidal compositions' [patent_app_type] => 1 [patent_app_number] => 7/037322 [patent_app_country] => US [patent_app_date] => 1987-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8282 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/832/04832729.pdf [firstpage_image] =>[orig_patent_app_number] => 037322 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2457314 [patent_doc_number] => 04784998 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1988-11-15 [patent_title] => '1,3,4-oxadiazole pyschotropic compounds' [patent_app_type] => 1 [patent_app_number] => 7/034372 [patent_app_country] => US [patent_app_date] => 1987-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1994 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/784/04784998.pdf [firstpage_image] =>[orig_patent_app_number] => 034372 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2445341 [patent_doc_number] => 04792607 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1988-12-20 [patent_title] => '5-fluoro-3,4-dihydro-2,4-dioxo-N-(3-indolyl)-1(2H)-pyrimidinecarboxamides' [patent_app_type] => 1 [patent_app_number] => 7/033497 [patent_app_country] => US [patent_app_date] => 1987-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9157 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/792/04792607.pdf [firstpage_image] =>[orig_patent_app_number] => 033497 [rel_patent_id] =>[rel_patent_doc_number] =>)